TMCnet News
MEDIA ADVISORY -- Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World ConferenceADVISORY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- WHAT: Dr. Heinrich Roder, Biodesix’ CTO, will speak on “Applied Machine Learning for Immuno-Oncology Diagnostics” in the “AI and Data Science Showcase” track at the Precision Medicine World Conference (PMWC) in Mountain View, CA. WHO: Heinrich Roder is a company founder and author or co-author of more than 100 publications and talks spanning the fields of theoretical physics, computational sciences, and molecular diagnostics. A Rhodes Scholar, he earned his DPhil in Theoretical Physics from the University of Oxford and has held positions at the Universities of Hanover and Bayreuth and at Los Alamos National Laboratory. He is a founder of Biodesix. Serving as CTO, he leads the work of the Research and Development team on sensitive, high-throughput MALDI-ToF mass spectrometry pofiling of blood-based samples. His team develops molecular diagnostic tests using a proprietary analytics platform based on machine learning. WHEN/WHERE: Monday, January 22nd, 10:30AM PST, at the Computer History Museum, 1401 N. Shoreline Blvd, Mountain View, CA. About Biodesix For more information about Biodesix, please visit www.Biodesix.com. Contact: Rachel Biederman |